ClinConnect ClinConnect Logo
Search / Trial NCT06548386

Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks

Launched by LUNG HEALING TECHNOLOGIES INC · Aug 8, 2024

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Alveolopleural Fistula

ClinConnect Summary

This clinical trial is looking into a new device designed to help doctors detect air leaks from the lungs, a condition known as pneumothorax. The device is a gas analyzer that can be attached to a chest drain, which is a tube used to remove air or fluid from around the lungs. By measuring gases like carbon dioxide and oxygen, this analyzer aims to provide important information that can help diagnose and treat air leaks more effectively than just relying on visual bubbles in the water seal of the drain.

To participate in this trial, patients need to be scheduled for thoracic surgery and expect to have a chest tube placed afterward. Participants must be over 18 years old and capable of giving informed consent, but if someone cannot sign for themselves, a legally appointed representative can do it for them. However, patients who are pregnant, have unstable health conditions, or are minors will not be eligible to join. This study is currently not recruiting participants yet, but it aims to improve care for those dealing with lung air leaks.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients who are scheduled for thoracic surgery and expected to have chest tube placed
  • 2. For patients who are unable to sign consent, but meet all of the inclusion criteria and none of the exclusion criteria, a legally appointed representative (LAR) will be allowed to sign consent for that patient
  • 3. Patients that provide informed consent for the study
  • 4. Patients \>18 years old
  • Exclusion Criteria:
  • 1. Patients with hemodynamic instability
  • 2. Pregnant patients
  • 3. Prisoners
  • 4. Individuals who are not yet adults

About Lung Healing Technologies Inc

Lung Healing Technologies Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative therapies for respiratory diseases. With a focus on developing cutting-edge solutions that promote lung health and recovery, the company leverages state-of-the-art research and technology to address unmet medical needs in pulmonary care. Committed to rigorous scientific standards and patient safety, Lung Healing Technologies Inc. collaborates with leading healthcare professionals and institutions to facilitate clinical trials that aim to improve treatment outcomes and enhance the quality of life for individuals suffering from chronic lung conditions.

Locations

Evanston, Illinois, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported